An integrated microfluidic sample-to-answer system for automated detection of common deletional α-thalassemia mutations
Analytica Chimica Acta · 2026
DOI: 10.1016/j.aca.2026.346236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026. Verfasst von Yilian Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Joint Inspection Center of Precision Medicine, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, Nan…. Hauptthemen laut MEDLINE: alpha-Thalassemia, Microfluidic Analytical Techniques, Sequence Deletion, Lab-On-A-Chip Devices. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Thalassemia is a prevalent hereditary hematological disorder, and rapid, automated genetic screening is essential for large-scale prevention and control, particularly in primary healthcare settings. To address the limitations of conventional molecular diagnostic methods, we developed an integrated microfluidic sample-to-answer system for simultaneous detection of four common deletional α-thalassemia mutations (-α3.7, -α4.2, --SEA, and --THAI), together with the HBA2 wild-type locus, enabling accurate discrimination between heterozygous and homozygous deletion genotypes. The system directly uses whole blood without nucleic acid extraction and integrates direct multiplex PCR (dmPCR) with reverse dot blot (RDB) hybridization in a fully closed microfluidic chip, enabling highly automated sample-to-result analysis within 3.5 h while minimizing contamination risk. The RDB-dmPCR assay demonstrated high analytical performance, including a limit of detection of 0.1 μL of whole blood, excellent specificity without cross-reactivity with non-deletional α- or β-thalassemia, strong reproducibility, and robust anti-interference capability. Clinical validation using 97 samples for the RDB-dmPCR assay and an independent cohort of 40 samples for the integrated microfluidic platform achieved 100% sensitivity, 100% specificity, and complete concordance with the reference gap polymerase chain reaction (Gap-PCR) method. By integrating amplification, hybridization, and result interpretation into a single automated workflow, this platform simplifies molecular testing and provides a practical solution for decentralized thalassemia screening in primary healthcare and other resource-limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Joint Inspection Center of Precision Medicine, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, Nanning, Guangxi, China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Center for Reproductive Medicine and Genetics, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, Nanning, Guangxi, China. Electronic address: heroandgirl@163.com.
- Joint Inspection Center of Precision Medicine, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, Nanning, Guangxi, China. Electronic address: zzchen@gxams.org.cn.
Zitieren
APA
Zhao, Y., Wei, Y., Ye, C., Ma, J., Liu, X., Xie, M., Zhou, X., Yu, X., Qing, J., & Chen, Z. (2026). An integrated microfluidic sample-to-answer system for automated detection of common deletional α-thalassemia mutations. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2026.346236
Vancouver
Zhao Y, Wei Y, Ye C, Ma J, Liu X, Xie M, et al. An integrated microfluidic sample-to-answer system for automated detection of common deletional α-thalassemia mutations. Analytica Chimica Acta. 2026. doi:10.1016/j.aca.2026.346236
BibTeX
@article{Zhao2026,
author = {Zhao, Yilian and Wei, Yan and Ye, Chao and Ma, Jinghui and Liu, Xinchu and Xie, Mengru and Zhou, Xiaoxing and Yu, Xia and Qing, Jilin and Chen, Zhizhong},
title = {An integrated microfluidic sample-to-answer system for automated detection of common deletional α-thalassemia mutations},
journal = {Analytica Chimica Acta},
year = {2026},
doi = {10.1016/j.aca.2026.346236}
}
EUVIMED